| Bioactivity | GSK932121 is an antimalarial drug with activity that inhibits the electron transport chain of P. falciparum. GSK932121 acts selectively on this pathogen at the level of cytochrome bc1 (complex III). The synthesis method of GSK932121 is highly efficient, and the final structure can be obtained in only 5 steps. The synthesis of GSK932121 can be prepared atKilog scale to support clinical studies[1]. |
| CAS | 958457-44-8 |
| Formula | C20H15ClF3NO4 |
| Molar Mass | 425.79 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Isoxazole mediated synthesis of 4-(1H)pyridones: improved preparation of antimalarial candidate GSK932121 |
GSK932121
CAS: 958457-44-8 F: C20H15ClF3NO4 W: 425.79
GSK932121 is an antimalarial drug with activity that inhibits the electron transport chain of P. falciparum. GSK932121 a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.